Resistance to TGFβ suppression and improved anti-tumor responses in CD8+ T cells lacking PTPN22
TGFβ secretion in the tumor microenvironment inhibits T cell-mediated anti-tumor immune responses. Here the authors show that a mutation predisposing to autoimmune diseases confers T cells resistance to TGFβ inhibitory action and could be exploited to engineer immunotherapies for TGFβ secreting tumo...
Main Authors: | Rebecca J. Brownlie, Celine Garcia, Mate Ravasz, Dietmar Zehn, Robert J. Salmond, Rose Zamoyska |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-01427-1 |
Similar Items
-
Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2
by: Cara Bray, et al.
Published: (2018-11-01) -
PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion
by: Johanna A. Knipper, et al.
Published: (2020-01-01) -
Studies of the protein tyrosine phosphatase PTPN22/Lyp in Ptpn22 deficient mice
by: Sanchez-Blanco, Cristina
Published: (2015) -
PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis.
by: Hui-Hsin Chang, et al.
Published: (2012-01-01) -
Familial autoimmune thyroid disease and PTPN-22
by: Gabriel Conzuelo Rodríguez, et al.
Published: (2015-08-01)